Vitiligo Prevalence and Patient Burden

John E. Harris, MD, PhD, reviews factors that shape prevalence of vitiligo and also explores the impact of vitiligo on patient quality of life.

Related Content:

Vitiligo: Practical Considerations for a Changing Therapeutic LandscapeVitiligo

T-VASI, F-VASI are Reliable Tools to Measure Nonsegmental Vitiligo Progress

How to Approach Disorders of Pigmentation, with Valerie Callender, MD

Ruxolitinib Cream Led to Meaningful Repigmentation Across Different Body Regions